AZoLifeSciences on MSN12 天
OGT introduces new NGS SureSeq Myeloid MRD Panel to detect ultra-low frequency MRD ...
OGT’s new highly targeted SureSeq Myeloid MRD Panel enables the detection of 13 key AML MRD-associated biomarkers ...
PharmiWeb16 天
OGT delivers superior MRD detection capabilities with new SureSeq Myeloid MRD Panel
Today, OGT announces the North American launch of its new next-generation sequencing (NGS) SureSeq™ Myeloid MRD Panel, which provides a flexible NGS workflow for the detection of ultra-low frequency ...